Human Anatomy, Physiology, and Medicine. Anything human!
Am I correct in assuming the 2 registered mail contacts were not to Mr. Rutz directly?
Along with the DVD in the registered mail communication did you or your offiliate(s) include accurate documentaion and direction in order for the CDC to be able to duplicate your findings?
The 14 visits made by CDC were made how? Hits on website or by other means?
I echo your fustration.
Dan Rutz is the chosen voice to the public, but do you really think he knows of all correspondance and everything that goes on within the CDC in referance to our condition?
Since I am the noob here, I'll let you in on a few things about myself. Unlike Al Gore, I really did help invent the internet. I have worked in internetworking since the time when we only had a couple of universities connected. I don't get worked up over flames, and I don't have the time to argue.
Electrionics is my gig, and therefore I know a little about light emitting diodes. LED array assemblies are sufficient for cool weather, moderate light requirement crops, whereas full sun crops require higher photon emission. No, LEDs will not grow pot, but that stuff just supresses your immune system anyway. There are many good books available on growing crops indoors. I have a set of onion seedlings growing under LEDs now that are just about ready for transplant.
One thing that you may be interested in London, is that I frequently have to splice optical fiber cable when constructing or trouble shooting FDDI links on network systems. I have been lurking and watching your optic fiber therory with great interest.
RUTZ IS LYING!!!! if he did say he had not heard of nor viewed the video presented by tamtam. Not only did tam bring this to the cdc personally in 2004, i began asking rutz directly about it in may of this year. In fact it was only a few weeks before the announced plan to study this disorder. coincidink? i think not. I can state with 95% certainty that rutz has viewed the video simply by the CDC visits to my site. I can verify ip addresses and because I get the impression that Rutz has an enourmous ego, the CDC visitor who has several times used the search terms of "dan Rutz crossinglines.net" where made by him. I have all the who's the whats the whens and what was looked at on my site, where they came from and where they exited to from given links. My site has seen approx 160,000 individual unique visitors and of all the corporations/business domains having visited, the CDC is 18th on the list. several ip's from the cdc domain have accounted for dozens and dozens of visits. so clearly you have busted them LYING TO THE PUBLIC OF WHICH THEY SERVE. Get mad people this is an outrage.
To read the correspondence with myself and Rutz visit this link.
http://www.crossinglines.net/communicat ... he_cdc.htm
This does it, man, I am seriously pissed off. more on that to follow.
And to Dan Rutz, as I am certain you visit this site, these words are meant for you. YOU ARE A LIAR!!. We personally spoke about this video in our telephone conversation last month. The CDC, as well the CFID and the NIH can and should expect a lawsuit concerning their lack of vigilance and apparent lack of competency with likely corporate collusion.
Asshole liar, We seriously need more accountability concerning how our taxes are being spent as this guys salary is being paid by all working americans. Lie to your boss once, you should be canned. period
"First they ignore you...
Then they laugh at you...
Then they fight you...
Then you win." - Mahatma Gandhi
Oh yeah really Frank?
Well, thanks for being honest at least. I bet I can guess your name in 3 guesses. If I do, will you be honest and tell me....actually , Ibet I can guess it in two guesses......I really think I can Frank.....
want me to try> of course, respect, yes, it would be in a pm.....
and Frank, i bet you use type 37 or type 65, etc., huh?
thankz for the link south....... for some local isp blocked that link in past..
..crosslines werx now
This is the most terrible news I have heard today. They have had these videos for 2 years and act as if they know nothing. I for one am furious.
What happened to the late great usofa? coverups. conspiracies. at our expense.
CDC has been informed twice via registered mail including DVD in 2004.
The visits made by CDC Institute counts 14 (fourteen) since april 2005.
"Cryptococcus neoformans" is what scare the sh#$% out of me.
where Unlike Al Gore, Frank has an opposite effect....
optic fiber dust must come with an MSDS sheet ..... how exactly is the saftey protocall implace. whatvabout those super macrophage vitural human genom biomarker signal transduction PHANTOMS that exist in the WIRE kept in the DOPed junctions......
is there a single saftey protocall for optic/silica dust for federal /civilian?
to all, yuck, look what this good dr. did. (i'm sure he had consent though)
Dr. Tomlinson, you're a bad man and your'e gonna rot in hell
Principle Investigator: Dr. William Thomlinson
Project started in: 1986
DOE: Office of Health and Environmental Research (OHER)
Amount: $50,000 (Est.)
Information on Use of Human Subjects:
Project does not involve use of multiple protocols/subprojects. Jeez., thanks man!
Type of Review: Full Board
Most Recent Approval: June 07, 1995
Number of Human Subjects in the Last Reporting Period for this Project: 2
(Reporting periods vary.)
Type of Human Subjects Involvement:
Ionizing Radiation and Radioactive Substances:
External use of ionizing radiation on human subjects.
For diagnostic research.
Internal use of chemical substances (solid, liquid, or gas) in human subjects.
For diagnostic research.
Instrument/Device/Product Testing or Man-Machine Studies:
Use of human subjects to develop/test instruments, materials, devices, or objects.
- funny, i don;t remember being asked......a-holes
(a. Objectives, b. Methodology, c. Ionizing Radiation, Radioactive Substances, or Chemical Substances to which human subjects are exposed, d. Involvement of Human Subjects [d.1. procedures used, d.2. risks if any])
This project is developing the application of synchrotron radiation sources to the imaging of human coronary arteries. The principal purpose is to image the arteries with a technique which has minimal risk for the patient. This study uses a venous injection of iodinated contrast agent. To date, the program has focused on the human related technical parameters of the procedure, such as contrast injection rates and volumes, timing of image sequences, and patient position. Simultaneously, upgrades of the imaging and x-ray optical systems have occurred. The program plans to image 70 patients in total, with possibly 30 patients being imaged twice. It is anticipated that some of these studies will become part of an expanded research program involving many more studies over a period of years. Those studies will focus on qualitative and quantitative characterization of arterial disease, pre- and post-treatment evaluation, and potential drug therapies. A potential effect of radiation is the induction of cancer. However, no harm in a human individual or in a large population exposed at doses as low as those delivered in this study has been reported. The estimation of risk of harm can be obtained only by extrapolation from much higher doses. Risks from the procedure may include severe allergic reaction to the iodine-containing dye, mechanical tear of a vein, local bleeding, impaired kidney function, and reaction to local leakage of the dye. Other complications may include blood clots, irregularities of heart beat, heart attack and death. The likelihood of serious complications is believed to be less than 0.5 percent.
I'll PM you tonight in the romeo time zone. You remind me of myself a couple of years ago when I was in really bad shape and getting worse. I was ready to grab an MD by the throat a couple of times, so I can empathize with your comments.
I really don't know the specs on the cable when I work with it. The engineers order it, the grunts install it, I cut it, fuse it or termnate a connector, and test it for refraction and loss. I suppose I could ask the engineers or get the product number off of the sheath. It's just not something that tech's concern orselves with.
okay, that would be nice. did you ever take or teach a course in neural networks, Frank? You can tell me later. I don;t know anything about computers nor biotechnology but I surprised myself and prob most of them when I figured it out (the porhyrins!)
i JUST HOPE YOU DO NOT; OR HAVE NOT worked for scummy Bell Labs. Ma Bell is going to Hell Frank. She is.
Talk to you later....
To develop techniques and procedures for processing tissue, extracting and storing collagen, and spinning and weaving collagen fibers into fabrics and other forms suitable for human prostheses that could induce the body’s own cells to rebuild lost tissue while gradually replacing the prosthesis.
Duration: 3/1/1993 — 2/28/1996
ATP Number: 92-01-0133
FUNDING (in thousands):
ATP $1,999 48%
Company 2,128 52%
TE accomplished its technical goals. The company developed procedures for processing a tissue-specific extracellular matrix rich in cytokines (cell-generated proteins), extracting and storing type I collagen (a material present in all tissues), and spinning collagen into fibers that can be woven into prosthetic fabrics. The company:
received two patents for technologies related to the ATP project: “Apparatus and Method for Spinning and Processing Collagen Fiber”
(No. 5,562,946: filed 11/2/1994, granted 10/8/1996) and “Bipolymer Foams Having Extracellular Matrix Particulates”
(No. 5,709,934: filed 11/22/1994, granted 1/20/1998);
applied for three other patents related to the technology;
made several presentations at conferences and workshops; and
formed a joint venture with Wright Medical Technology, Arlington, Tenn., to develop and distribute products based on the ATP-funded technology for applications involving ligaments, tendons, cartilage, and other musculoskeletal parts.
CITATIONS BY OTHERS OF PROJECT’S PATENTS: See Figure 3.3.
Prototypes are in testing, although no product has yet entered the market. Patent disclosures and a joint venture to commercialize the technology may be providing useful knowledge to other researchers in the field.
This project is on track for market entry in the very near future. The technology is scheduled to be used first in the fabrication of periodontal prostheses and orthopedic applications. Ideas for skin and wound-healing products are also being explored by the company with potential customers
sorry this is so long, but it;s from the you know who....and this pretty much sums this all up, eh?
ERASED BY lONDON B/C i HAD NOT THOUROUGLY READ IT MYSELF....SORRY!
Last edited by London on Wed Dec 20, 2006 8:23 pm, edited 1 time in total.
Revenge of the Nerds 2
any body but rushlimbo and myself have an oxycontin perscription?.....
Affinity identification of delta-opioid receptors using latex nanoparticles.
M Hasegawa, H Ohno, H Tanaka, M Hatakeyama, H Kawaguchi, T Takahashi, H Handa
Frontier Collaborative Research Center and Faculty of Bioscience and Biotechnology, Tokyo Institute of Technology, Nagatsuda, Yokohama 226-8501, Japan.
Three types of latex nanoparticles carrying naltrindole (NTI) derivatives were synthesized as probes for the affinity isolation of their binding proteins including the delta-opioid receptor. The effect of the attachment of NTI to different positions on the linker was investigated. Only latex nanoparticles in which the NTI derivative was linked through the phenol group were useful for isolating the recombinant delta-opioid receptor solubilized from CHO cell membrane. These latex nanoparticles could be a useful tool for investigations of the pharmacological activity of NTI.
[Pubmed Record - new window]
Synthesis and characterization of poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide]-g-poly(L-lactide) biodegradable copolymers as drug carriers.
T Peng, SX Cheng, RX Zhuo
Key Laboratory of Biomedical Polymers of Ministry of Education, Department of Chemistry, Wuhan University, Wuhan 430072, People's Republic of China.
"they'll make their own mark of the beast for us!"
A series of biodegradable amphiphilic graft polymers were successfully synthesized by grafting poly(L-lactide) (PLLA) sequences onto a water-soluble polymer poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide] (PHEA) backbone. We established the feasibility of preparing these novel graft polymers by the ring-opening polymerization initiated by the macroinitiator PHEA bearing hydroxyl groups without adding any catalyst. The successful grafting of PLLA sequences onto the PHEA backbone was verified by combined size exclusion chromatography (SEC) and multiangle laser light scattering (MALLS) analysis. The chemical structures of graft polymers were characterized by FTIR and (1)H NMR. The critical micelle concentration (CMC) of the graft polymer was determined by fluorescence probe technique using pyrene. By controlling the feed ratio of the macroinitiator to the monomer, graft polymers with different branch lengths can be obtained. Using the 3-(4,5 dimethylthiozol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay, the graft copolymer has been proved to have low cytotoxicity. Based on the amphiphilicity of the graft copolymers, nanoparticular drug delivery systems were prepared by the direct dissolution method and the dialysis method. The anticancer drug Tegafur was encapsulated into polymeric nanoparticles, and in vitro drug release behavior was investigated. Transmission electron microscopy (TEM) images demonstrate that these nanoparticles are regularly spherical in shape. The particle size and distribution of the nanoparticles were measured. (c) 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2006.
[Pubmed Record - new window] Spray freezing into liquid versus spray-freeze drying: Influence of atomization on protein aggregation and biological activity.
CHEMTRAILS per condensate anyone?????????????
Protein aggregation and enzyme activity were compared for reconstituted lysozyme particles produced by two cryogenic technologies, spray freezing into liquid (SFL) and spray-freeze drying (SFD). The particles were characterized by enzyme activity measurements, scanning electron microscopy (SEM), light scattering, X-ray photoelectron spectroscopy (XPS) and BET specific surface area analysis. Highly porous microparticle aggregates of protein nanoparticles, observed by SEM, were produced by both processes. The smaller degree of protein aggregation and smaller losses in enzyme activity for the SFL process relative to the SFD process were due primarily to the spraying step. The higher stability of the SFL versus SFD powders was consistent with the smaller surface excess of lysozyme measured by XPS in SFL, resulting from the reduced time of exposure to the air-water interface during atomization. For pure lysozyme, the degree of aggregation and enzyme activity were comparable for lyophilization and SFL, despite the much larger particle surface area for SFL.
[Pubmed Record - new window]
slowdown london you off the planet
I kknow iknow....... . .
its a SCALAR thing you just cant understand......or I know just how that teacher felt! I was able to go down on............whaattt!!!!!!!!!!!!!!!!!
any one grown your own cannibus knows bat guano makes great dank but...
any microbiologist know where to get cryptococcos neoformans......
duel use across the consumer grade market .....................
man some evil mad jo jo jo jo at werk im spectin
Last edited by Nadas Moksha on Wed Dec 20, 2006 8:28 pm, edited 1 time in total.
Who is online
Users browsing this forum: No registered users and 5 guests